Mad Hedge Hot Tips
March 21, 2019
The Five Most Important Things That Happened Today
(and what to do about them)
1) The Fed Eases Again, by cutting short their balance sheet unwind and ending quantitative tightening early. It amounts to two surprise interest rate cuts and is hugely “RISK ON”. New highs in stocks beckon. This is a game changer. Click here.
2) Biogen Blows Up, canceling their phase three trials for the Alzheimer drug Aducanumab. This is the worst-case scenario for a biotech drug and the stock is down a staggering 30%. Some $12 billion in prospective income is down the toilet. Avoid (BIIB) until the dust settles. Click here.
3) Micron Technology Comes in Line, with weak guidance and production cutbacks, but the shares soar anyway. Go figure. Investors really want to get into this stock in the worst way, even though the industry is still in its down cycle. Click here.
4) Europe Fines Google $1.7 Billion, in the third major penalty in three years. Clearly, there’s a “not invented here” mentality going on. It’s sofa change to the giant search company. Buy (GOOG) on the dip. Click here.
5) Levi Strauss is a Hit, with the shares soaring 35% from the first day IPO price of $17. It’s interesting that the Haas family is unloading their legacy shares at this point in the economic cycle while still maintaining control of the iconic denim maker. Avoid (LEVI). Click here.
Published today in the Mad Hedge Global Trading Dispatch and Mad Hedge Technology Letter:
(DIVING BACK INTO THE MOUSE HOUSE),
(THE ALPHABET NO-BRAINER),